Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) Return on Sales (2019 - 2025)

Historic Return on Sales for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to 0.22%.

  • Nexgel's Return on Sales rose 400.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year increase of 3300.0%. This contributed to the annual value of 0.4% for FY2024, which is 3800.0% up from last year.
  • Nexgel's Return on Sales amounted to 0.22% in Q3 2025, which was up 400.0% from 0.22% recorded in Q2 2025.
  • Nexgel's Return on Sales' 5-year high stood at 0.22% during Q3 2025, with a 5-year trough of 4.64% in Q1 2022.
  • Moreover, its 5-year median value for Return on Sales was 1.02% (2022), whereas its average is 1.33%.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 50300bps in 2021, then plummeted by -20000bps in 2022.
  • Nexgel's Return on Sales (Quarter) stood at 1.66% in 2021, then skyrocketed by 39bps to 1.02% in 2022, then decreased by -7bps to 1.1% in 2023, then surged by 75bps to 0.27% in 2024, then rose by 19bps to 0.22% in 2025.
  • Its last three reported values are 0.22% in Q3 2025, 0.22% for Q2 2025, and 0.24% during Q1 2025.